Skip to Content

'
Peter W. Pisters, M.D., F.A.C.S.

Present Title & Affiliation

Primary Appointment

Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Office Address

The University of Texas M. D. Anderson Cancer Center
1400 Holcombe Blvd.
PO Box 301402
Unit Number: 444
Houston, TX 77230-1402
Room Number: FC12.2024
Phone: 713-794-1572
Email: ppisters@mdanderson.org

Education & Training

Degree-Granting Education

1985 University of Western Ontario, London, Ontario, Canada, MD, Medicine
1981 University of Western Ontario, London, Canada, BS, Biology

Postgraduate Training

7/1993-6/1994 Chief Administrative Fellow, Surgical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, Murray F. Brennan, M.D.
7/1992-6/1994 Clinical Fellowship, Surgical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, Murray F. Brennan, M.D.
7/1989-6/1992 Senior and Chief Resident, General Surgery, New York University Medical Center-Bellevue Hospital Center, New York, NY, Frank C. Spencer, M.D.
7/1987-6/1989 Research Fellowship, Surgical Metabolism Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, Murray F. Brennan, M.D.
7/1985-6/1987 Intern and Junior Resident, General Surgery, New York University Medical Center - Bellevue Hospital Center, New York, NY, Frank C. Spencer, M.D.

Board Certifications

1993 American Board of Surgery

Experience/Service

Administrative Appointments/Responsibilities

Clinical Consultant, The University of Texas M. D. Anderson Cancer Center, Center for Global Oncology, Houston, TX, 7/2008-present

Honors and Awards

2000 Outstanding Teacher Award, U. T. M. D. Anderson Cancer Center
1998-1999 Faculty Excellence Award, U.T. M. D. Anderson Cancer Center
1997-1998 Faculty Excellence Award, U.T. M. D. Anderson Cancer Center
1997 Outstanding Teacher Award, U.T. M. D. Anderson Cancer Center
1996-1997 Faculty Excellence Award, U.T. M. D. Anderson Cancer Center

Professional Memberships

American Board of Surgery, Austin, TX
Member, Task Force, ABS Advisory, 9/2007-9/2008
Surgical Oncology Advisory Council Member, 10/2001-10/2002
Associate Examiner, 10/2000-present
American College of Surgeons, Chicago, IL
Member, AJCC Soft Tissue Sarcoma Task Force, 9/2007-present
American College of Surgeons Oncology Group
Co-Chair, Gastrointestinal Organ Site, 2006-present
Member, Executive Committee, 2004-present
Chair, Sarcoma Committee, 2001-2005
American College of Surgeons, Commission on Cancer National Sarcoma Patterns of Care Committee
Disease Site Team, 2002-present
Member, Gastric Cancer, 2000-present
Member, Soft Tissue Sarcoma, 1995-present
American College of Surgeons, Commission on Cancer Quality Integration Committee
Cancer Quality Measure Development (CQMD) Pancreatic Cancer Expert Panel, 9/2007-9/2008
Executive Committee, 2004-present
Professional Program Planning Subcommittee, 2004
Chairman, 2002-present
Vice-Chair, 2000-2001
Member, Oncology Group (ACOSOG) Pancreas Organ Site Committee, 1998-present
Member, Oncology Group (ACOSOG) Sarcoma Organ Site Committee, 1998-present
American College of Surgeons, Commission on Cancer Quality Measure Development (CQMD), Chicago, IL
Pancreatic Cancer Expert Panel, 9/2007-9/2008
American Society of Clinical Oncology
Member, People Living with Cancer (PLWC), Advisory Panel, 2007-present
Roster of Cancer Experts, 2005-2008
Member, Cancer Education Committee, 2002-present
Track Team Member, Gastrointestinal Cancer, 2002-present
Web site Advisory Panel, 2002-present
Track Team Leader, Sarcoma/Bone and Soft Tissue Cancer, 2002-2003
Task Force on Associate/Junior Members, 5/2001-present
American Surgical Association
Member, 7/2008-present
Connective Tissue Oncology Society
Database Committee, 2000
Connective Tissue Oncology Society
Program Committee, 2000
Moderator, Surgical Oncology Session, 1998
Moderator, Symposium on Early Stage Sarcoma, 1997
Member, International Database Committee, 1996-1998
Desmoid Tumor Research Foundation
Advisory Board, 2005-present
GI Stromal Tumors (GIST) Task Force, Bethesda, MD
Member, 7/2008-present
National Cancer Institute, Bethesda, MD
Reviewer for Subcommittee H, 11/2007-12/2007
National Cancer Institute (GIST Task Force), Bethdesda, MD
Member, 6/2008-present
National Cancer Institute (Sarcoma Task Force), Bethesda, MD
Member, 1/2008
National Comprehensive Cancer Network (NCCN), Boston, MA
Member, 1/2007-present
Ntional Cancer Institute (Pancreas Task Force), Bethesda, MD
Member, 1/2008
Pancreas Cancer Action Network (PANCAN), CA
Medical Advisory Board, 2000
Radiation Therapy Oncology Group
Chairman, Surgical Oncology Committee, 2001-present
Group, Vice-Chair, Surgery, 2001-present
RTOG Steering Committee, 2001-present
Soft Tissue Sarcoma Working Group, 1999-present
Chairman, Surgical Quality Control Committee, 1999-2005
Sarcoma Foundation of America
Advisory Board, 2000-present
Society of Surgical Oncology
Member, ABS Advisory Task Force, 2006-present
Member, Executive Council, 2006-present
Member, Nominating Committee, 2004
Counselor-at-Large, Executive Council, 2002-2005
Chairman, Training Committee, 1999-2002
Member, Membership Committee, 1999-2002
Member, Program Directors Committee, 1999-2002
Western Surgical Association
Advisory Nominating Committee, 2012
Member, Membership Committee, 2011-2012
District Representative, 2009-2012
Member, Program Committee, 2009-2010
Chairman, Program Committee, 2008
Member, Program Committee, 2004-2008
Yonsei Cancer Center, Seoul, Korea, Republic of
External Advisory Board, 2006-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PWT, Demetri GD, Blackstein Me, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K. Adjuvant imatinib mesylate after resection of localized, primary gastrointestinal stromal tumor: a randomized, double-blind, placebo-controlled trial. Lancet 373(9669):1097-104, 03/28/2009, 3/2009.
2. Anaya DA, Lahat G, Wang X, Xiao L, Tuvin D, Pisters PW, Lev DC, Pollock RE. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. Ann Surg Oncol 16(3):667-75, 3/2009. PMID: 19101765.
3. Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 144(3):216-21, 3/2009. PMID: 19289659.
4. Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16(4):836-47, 2/2009. PMID: 19194760.
5. Anaya DA, Lahat G, Liu J, Xing Y, Cormier JN, Pisters PWT, Lev DC, Pollock RE.. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 249(1):137-42, 2009. PMID: 19106689.
6. Lim SJ, Cormier JN, Feig BW, Mansfield PF, Benjamin RS, Griffin JR, Chase JL, Pisters PWT, Pollock RE, Hunt KK. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol 14(8). e-Pub 6/2008.
7. Overman MJ, Fogelman D, Al-Kali A, Crane CH, Evans D, Abdalla EK, Pisters PWT, Kopetz S, Eng C, Wolff RA. Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases. Clin Colorectal Cancer 7(5):338-42, 2008.
8. Katz MH, Fleming JB, Pisters PWT, Lee JE, Evans DB.. Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. Ann Surg 248(6):1098-102, 2008. PMID: 19092356.
9. Badgwell B, Cormier JN, Xing Y, Yao J, Bose D, Krishnan S, Pisters PWT, Feig BW, Mansfield PF.. Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol 16(1):42-50, 2008. e-Pub 11/5/2008. PMID: 18985270.
10. Katz MHG, Wolff RA, Pisters PWT, Sun CC, Evans DB, Varadhachary GR, Fleming JB, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surgeons 5(206):833-46, 2008.
11. Cormier JN. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with the data from the Surveillance, Epidemiology, and Ends Results of Registry". Cancer, 2008.
12. Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PWT, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 15(5):1356-66, 2008.
13. Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, Pisters PWT, Feig B, Mansfield P. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 15(10):2684-91, 2008.
14. Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PWT, Evand DB, Abdalla EK, Thomas MB, Brown T, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 15(11):147-56, 2008.
15. Reed VK, Krishnan S, Mansfield PF, Bhosale PR, Kim M, Das P, Janjan NA, Delclos ME, Lowy AM, Feig BW, Pisters PWT, Ajani JA, Crane CH. Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 71(3):741-7, 2008.
16. Al-Refaie WB, Andtbacka RH, Ensor J, Pisters PWT, Ellis TL, Shrout A, Hunt KK, Cormier JN, Pollock RE, Feig BW. Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer 112(8):1821-6, 2008.
17. Demartelaere SL, Roberts D, Burgess MA, Morrison WH, Pisters PW, Sturgis EM, Ho V, Esmaeli B. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement. Head Neck 30(5):639-46, 2008.
18. Lahat G, Tuvin D, Wei C, Anaya DA, Bekele BN, Lazar AJ, Pisters PWT, Lev D, Pollock RE. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol 15(10):2739-48, 2008.
19. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PWT, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(20):3487-95, 2008.
20. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PWT, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3496-502, 2008.
21. Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos M, Janjan N, Wolff R, Crane C, Pisters PWT. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. Cancer 70(3):735-43, 2008.
22. Picozzi VJ, Pisters PWT, vickers SM, Strasberg SM. Strength of the evidence: adjuvant therapy for resected pancreatic cancer. J Gastrointest Surg 12(4):657-61, 2008.
23. Al-Refaie WB, Tseng JF, Gay G, Patel-Parekh L, Mansfield PF, Pisters PWT, yao JC, Feig BW. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma: results from the National Cancer Database. Cancer 113(3):461-9, 2008.
24. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PWT, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. XRCC2 and XRCC3 genes polymorphism and risk of pancreatic cancer. Am J Gastroenterol 103:360-67, 2008.
25. Patel PR, Mansfield PF, Crane CH, Wu TT, Lee JH, Lynch PM, Morris J, Pisters PWT, Feig BW, Sunder PK, Izzo JG, Ajani JA.. Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer 110(5)(5):989-95, 9/2007. PMID: 17636525.
26. Lazar AJF, Das P, Korchin B, Jin Z, Warneke CL, Kotlingham D, Zhang PS, Lopez-Terrada D, Pisters PWT, Pollock RE. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma (ASPS). Clin Cancer Res 13(24):7314-21, 2007.
27. Aloia TA, Pisters PWT, Lee Je, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary G, Crane CH, Evans DB. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? J Am Coll Surg 204(3):347-55, 2007.
28. Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PWT, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach of gastroesophageal junction. Ann Surg Oncol 14(4):1305-11, 2007.
29. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwant R, Vauthey JN, Abdalla EK, Lee JE, Pisters PWT, Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246(1):52-60, 2007.
30. Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Pisters PWT, Benjamin RS, Pollock RE. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 69(4):1173-80, 2007.
31. Pisters PWT, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MT. Long-term results of prospective trial of surgery alone with selective use radiation treatment for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246(4):675-82, 2007.
32. Torres MA, Ballo MT, Butler CE, Feig BW, Cormier JN, Lewis VO, Pollock RE, Pisters PWT, Zagars GK. Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys 67(4):1124-29, 2007.
33. Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PWT, Lazar A, Patel SR, Benjamin RS, Pollock RE. Optimizing treatment of desmoid tumors. J Clin Oncol 25(13):1785-91, 2007.
34. Hassan M, Abbruzzese J, Bondy M, Wolff R, Vauthey JN, Pisters, PWT, Evans DB, Khan R, Lenzi R, Jiao L, Li D. Passive smoking and use of non-cigarette tobacco products in association with risk for pancreatic cancer. a case-control study. Internatl J Cancer 109(12):2547-56, 2007.
35. Lin PP, Pino ED, Normand AN, Deavers MT, Cannon CP, Ballo MT, Pisters PWT, Pollock RE, Lewis VO, Zagars GK, Yasko A. Periosteal margin in soft tisue sarcoma. Cancer 109(3):598-602, 2007.
36. Hannay JAF, Liu J, Bolshakov SV, Li L, Pisters PWT, Lazar AJF, Yu D, Pollock RE, Lev D. Rad51 over-expression contributes to chemoresistance in human soft tissue sarcoma: a role for p53/AP-2 transcriptional regulation. Mol Cancer Ther 6(5):1650-60, 2007.
37. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 67(1):158-63, 2007. PMID: 17084545.
38. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PWT, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102(12):2696-707, 2007.
39. Wallace MJ, Choi E, McRae S, Madoff DC, Ahrar K, Pisters PWT. Superior mesenteric artery pseudoaneurysm following pancreaticoduodenectomy: management by endovascular stent-graft placement and transluminal thrombin injection. CardioVasc Intervent Radiol 30:518-22, 2007. PMID: 17031732.
40. Andtbacka RHI, NG CS, Scaife CL, Cormier JN, Hunt KK, Pisters PWT, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 14(1):14-24, 2007.
41. Tseng JF, Pisters PWT, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB. The learning curve in pancreatic surgery. Surgery 141(4):456-63, 2007.
42. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13(8):1035-46, 2006. PMID: 16865597.
43. Cannon CP, Ballo MT, Zagars GK, Mirza AN, Lin PP, Lewis VO, Yasko AW, Benjamin RS, Pisters PW. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 107:2455-61, 2006. PMID: 17036354.
44. Huang X, Cormier JN, Pisters PW. Estimation of the causal effects on survival of two-stage nonrandomized treatment sequences for recurrent diseases. Biometrics 62(3):901-9, 2006. PMID: 16984334.
45. Al-Refaie WB, Choi EA, Tseng JF, Tamm EP, Lee JH, Lee JE, Evans DB, Pisters PW. Intraductal papillary mucinous neoplasms of the pancreas. Med Princ Pract 15(4):245-52, 2006. PMID: 16763389.
46. Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 13(4):582-94, 2006. PMID: 16523362.
47. Pawlik TM, Pisters PW, Mikula L, Feig BW, Hunt KK, Cormier JN, Ballo MT, Catton CN, Jones JJ, O'Sullivan B, Pollock RE, Swallow CJ. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 13:508-17, 2006. PMID: 16491338.
48. Rohatgi PR, Yao JC, Hess K, Schnirer I, Rashid A, Mansfield PF, Pisters PW, Ajani JA. Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival. Cancer 107(11):2576-80, 2006. PMID: 17075877.
49. Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24:1145-51, 2006. PMID: 16505434.
50. Ajani JA, Winter K, Okawara GS, Donohue JH, Pisters PW, Crane CH, Greskovich JF, Anne PR, Bradley JD, Willett C, Rich TA. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol 24(24):3953-8, 2006. PMID: 16921048.
51. Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27(1):103-11, 2006. PMID: 15987714.
52. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 106(7):1610-6, 2006. PMID: 16518798.
53. Raut CP, Pisters PW. Retroperitoneal sarcomas: Combined-modality treatment approaches. J Surg Oncol 94(1):81-7, 2006. PMID: 16788949.
54. Rohatgi PR, Mansfield PF, Crane CH, Wu TT, Sunder PK, Ross WA, Morris JS, Pisters PW, Feig BW, Gunderson LL, Ajani JA. Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma. Cancer 107(7):1475-82, 2006. PMID: 16944539.
55. Tseng JF, Ballo MT, Langstein HN, Wayne JD, Cormier JN, Hunt KK, Feig BW, Yasko AW, Lewis VO, Lin PP, Cannon CP, Zagars GK, Pollock RE, Pisters PW. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol 13(9):1209-15, 2006. PMID: 16952046.
56. Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14:1470-6, 2005. PMID: 15941958.
57. Muss HB, Von Roenn J, Damon LE, Deangelis LM, Flaherty LE, Harari PM, Kelly K, Kosty MP, Loscalzo MJ, Mennel R, Mitchell BS, Mortimer JE, Muggia F, Perez EA, Pisters PW, Saltz L, Schapira L, Sparano J. ACCO: ASCO core curriculum outline. J Clin Oncol 23(9):2049-77, 2005. PMID: 15728218.
58. Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, Pisters PW, Ballo MT, Chen L, Trent J, 3rd, Burgess M, Patel S, Pollock RE, Cormier JN. Angiosarcoma of the breast. Cancer 104:2682-8, 2005. PMID: 16288486.
59. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB. Carcinoid tumors of the duodenum. Surgery 138:971-7; discussion 977-8, 2005. PMID: 16360380.
60. Yao JC, Tseng JF, Worah S, Hess KR, Mansfield PF, Crane CH, Schnirer,, II, Reddy S, Chiang SS, Najam A, Yu C, Giacco GG, Xie K, Wu TT, Feig BW, Pisters PW, Ajani JA. Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years. J Clin Oncol 23:3094-103, 2005. PMID: 15860869.
61. Pisters PW, Wolff RA, Crane CH, Evans DB. Combined-modality treatment for operable pancreatic adenocarcinoma. Oncology (Williston Park) 19:393-404, 409; discussion 409-10, 412-6, 2005. PMID: 15828554.
62. Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140:584-9, 2005. PMID: 15967906.
63. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130(5):1391-8, 2005. PMID: 16256794.
64. Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, Janjan N, Feig B, Faust J, Yao JC, Nivers R, Morris J, Pisters PW. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 23(6):1237-44, 2005. PMID: 15718321.
65. Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9(8):1094-104, 2005. PMID: 16269380.
66. Windham TC, Pisters PW. Retroperitoneal sarcomas. Cancer Control 12:36-43, 2005. PMID: 15668651.
67. Cormier JN, Huang X, Xing Y, Thall PF, Wang X, Benjamin RS, Pollock RE, Antonescu CR, Maki RG, Brennan MF, Pisters PW. Cohort analysis of 674 patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 22:4567-74, 2004. PMID: 15542808.
68. Porter GA, Cantor SB, Walsh GL, Rusch VW, Leung DH, DeJesus AY, Pollock RE, Brennan MF, Pisters PW. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. J Thorac Cardiovasc Surg 127:1366-72, 2004. PMID: 15115994.
69. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys 58:1461-7, 2004. PMID: 15050324.
70. Ajani JA, Mansfield PF, Janjan N, Morris J, Pisters PW, Lynch PM, Feig B, Myerson R, Nivers R, Cohen DS, Gunderson LL. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol 22:2774-80, 2004. PMID: 15254045.
71. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8:935-49; discussion 949-50, 2004. PMID: 15585381.
72. Pisters PW, Patel SR, Prieto VG, Thall PF, Lewis VO, Feig BW, Hunt KK, Yasko AW, Lin PP, Jacobson MG, Burgess MA, Pollock RE, Zagars GK, Benjamin RS, Ballo MT. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol 22:3375-80, 2004. PMID: 15310783.

Last updated: 9/30/2009